Plasma Derived Drugs Market Key Highlights:
- Market Size (2024): USD 35.21 Billion
- Projected Market Size (2034): USD 73.24 Billion
- CAGR (2023-2034): 7.6%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Plasma Derived Drugs Market Definition
The plasma derived drugs market is a key niche within the biopharmaceutical market, addressing the treatment-oriented products made from human plasma. Such drugs are important for the management of various medical conditions, particularly those associated with a lack of proteins or immune system components, including hemophilia, immunodeficiencies, and autoimmune diseases. Plasma-derived drugs (PDDs) are human blood plasma-based medicines designed for therapeutic use in medical conditions characterized by a lack of antibodies or protein in the body. They play a very important role in the management of diseases that are rare and chronic, such as hemophilia, primary immune deficiency disorders, and other autoimmune diseases.
The plasma derived drugs market is becoming more prominent as more people are afflicted by these conditions along with the development in plasma collection and fractionation techniques. Important growth factors comprise the rising incidence of chronic rare conditions, enhanced awareness and prompt diagnosis, technology improvement for plasma collection and fractionation, and government and infrastructure funding. The above have contributed to higher diagnosis rates, better supply levels, and the growth of PDDs especially in emerging economies. Government reimbursement policies are of equal importance in ensuring that patients have access to these treatments.
Plasma Derived Drugs Market Segmentation:
By Type
- Immunoglobulins
- Albumins
- Clotting Factors
- Others
By Application
- Hospital
- Retail Pharmacy
- Other
Plasma Derived Drugs Market Companies:
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
